Bioherent Company
Bioherent develops in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics. Bioherent is based on integrated photonic sensors, and the company provides medical diagnostic tests for the detection of drug allergies. It develops sensitive, low-cost, in-vitro medical diagnostic technology. They develop in vitro diagnostic systems for the detection of allergies to beta-lactam antibiotics.
.png)
Funding Status:
private
Total Funding:
1543719
Industry:
Gyroscopy
Founded Date:
2021-01-01
Last Funding Date:
2025-07-17
Headquarters:
Alhaurín De La Torre,Andalucia,Spain,Europe
Employee Number:
11-50
Super Industry:
Quantum Sensing
Funding Stage:
Seed
Funding Total Value:
1365000